Rh-Endostatin (Endostar®) Continuous Intravenous Infusion

NCT03706703 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Endostar
DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Pemetrexed

Sponsor

Affiliated Cancer Hospital & Institute of Guangzhou Medical University